The effectiveness of mindfulness-based interventions in inflammatory bowel disease: A Systematic Review & Meta-Analysis.
Study Goal
The researchers aimed to systematically review the evidence on Mindfulness-Based Interventions (MBI) for improving biopsychosocial outcomes in individuals with Inflammatory Bowel Disease (IBD).
Results Summary
MBI was more effective than control groups in short-term improvements in stress, mindfulness, C-Reactive Protein (CRP), and health-related quality of life (HRQoL). Long-term benefits were maintained for stress and mindfulness but not for HRQoL, with no long-term data available for CRP.
Population
Individuals living with Inflammatory Bowel Disease (IBD).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Mindfulness-Based Interventions (MBI) | decrease | stress | individuals living with IBD | SMD = -0.38, 95% CI [-0.65, -0.10], p = 0.007 | were more efficacious than control groups in the short-term improvement of | #1 |
Mindfulness-Based Interventions (MBI) | increase | mindfulness | individuals living with IBD | SMD = 0.59, 95% CI [0.36, 0.83], p = 0.00001 | were more efficacious than control groups in the short-term improvement of | #2 |
Mindfulness-Based Interventions (MBI) | decrease | C-Reactive Protein (CRP) | individuals living with IBD | SMD = -0.25, 95% CI [-0.49, -0.01], p = 0.04 | were more efficacious than control groups in the short-term improvement of | #3 |
Mindfulness-Based Interventions (MBI) | increase | health-related quality of life (HRQoL) | individuals living with IBD | SMD = 0.45, 95% CI [0.24, 0.66], p = 0.0001 | were more efficacious than control groups in the short-term improvement of | #4 |
Mindfulness-Based Interventions (MBI) | decrease | stress | individuals living with IBD | SMD = -0.44, 95% CI [-0.88, -0.01], p < 0.05 | This was maintained in the long-term for | #5 |
Mindfulness-Based Interventions (MBI) | increase | mindfulness | individuals living with IBD | SMD = 0.52, 95% CI [0.14, 0.90], p = 0.008 | This was maintained in the long-term for | #6 |
Mindfulness-Based Interventions (MBI) | no change | HRQoL | individuals living with IBD | - | but not for | #7 |
Mindfulness-Based Interventions (MBI) | neutral | CRP | individuals living with IBD | - | with no long-term data available for | #8 |
BACKGROUND: Mental health has been identified as contributing to the pathogenesis of Inflammatory Bowel Disease (IBD). Resultingly, psychotherapeutic interventions, such as Mindfulness-Based Interventions (MBI), have been increasingly investigated for improving IBD outcomes. OBJECTIVES: To systematically review the current state of evidence of MBI's for individuals living with IBD. METHODS: We performed a systematic review searching Medline, PsychINFO, CINAHL, Embase, Cochrane and Scopus, to identify controlled clinical trials, investigating MBI's for various IBD biopsychosocial outcomes. Data was pooled using the inverse-variance random effects model, with restricted maximum likelihood estimation, providing the standardized mean difference (SMD) between control and experimental groups, at both short and long-term follow up. RESULTS: We identified 8 studies with 575 participants. Meta-analytic results found that MBI's were more efficacious than control groups in the short-term improvement of stress (SMD = -0.38, 95% CI [-0.65, -0.10], p = 0.007), mindfulness (SMD = 0.59, 95% CI [0.36, 0.83], p = 0.00001), C-Reactive Protein (CRP) (SMD = -0.25, 95% CI [-0.49, -0.01], p = 0.04) and health-related quality of life (HRQoL) (SMD = 0.45, 95% CI [0.24, 0.66], p = 0.0001) (including all emotional, bowel, social and systemic subscales). This was maintained in the long-term for stress (SMD = -0.44, 95% CI [-0.88, -0.01], p < 0.05) and mindfulness (SMD = 0.52, 95% CI [0.14, 0.90], p = 0.008), but not for HRQoL, with no long-term data available for CRP. CONCLUSIONS: Given that MBI's appear to be effective in improving several IBD outcomes, they may be a useful adjuvant therapy in wholistic IBD care, with further trials warranted.